G14 GER Week ended 07 Aug 2026

Weekly Investor Report

Signify N.V. · Industrials · Electrical Equipment & Parts

Open interactive chart View report data
Latest close 15.30 EUR
3.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -15.6% below the Trend Line and sits at 18.0% of its 52-week range. The latest completed week returned 3.5%, after a -7.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 45/100.

Setup score 26 out of 100
Latest Close 15.30 EUR 7 Aug 2026
1W Return 3.5% latest completed week
4W Return -7.8% short-term follow-through
12W Return -25.0% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Next-week expectancy is positive at 58.24% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.5% Latest completed week; four-week move -7.8%. Indicator stack 18/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 58.24% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 45/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -15.6% below the Trend Line and sits at 18.0% of its 52-week range. The latest completed week returned 3.5%, after a -7.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4812-week average 0.55

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.8% over four weeks, -25.0% over 12 weeks, and -25.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.5%
4W-7.8%
12W-25.0%
26W-17.7%
52W-25.1%
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.85Latest activity-pressure read.
Pressure change-691.1%Four-week change in activity pressure.
Leadership-25.23Latest relative-leadership reading.
RS change-49.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength74/100Blend of value, momentum, and quality. Underlying universe rank 27; rank 1 is best.
Value97/100Relative valuation strength. Underlying universe rank 4; rank 1 is best.
Quality32/100Profitability and accounting quality. Underlying universe rank 69; rank 1 is best.
Momentum14/100Medium-term price momentum. Underlying universe rank 87; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework83/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.8x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
5.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
39.5%
Gross profit retained from each unit of revenue.
Operating margin
5.0%
Operating profit retained from revenue.
Free-cash-flow margin
6.6%
Free cash flow generated from revenue.
Return on invested capital
5.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-6.2%
Latest one-year revenue growth.
EPS growth
-18.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-3.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
10.3%
Cash dividends relative to market value.
Buyback yield
6.2%
Net share repurchases relative to market value.
Shareholder yield
16.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment45/100

Weighted news tone is neutral across 3 relevant articles.

1 positive · 1 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.0%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+6.3%Week of 1 May.
Worst week-18.8%Week of 26 Jun.
Latest week+3.5%Week of 7 Aug.

Shape of recent returns

Strong gains2
Modest gains13
Flat weeks0
Modest losses6
Sharp losses5
Recent vol6.0%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis48/100

Latest 12-week confirmation: trend 5/12, activity pressure 7/12, relative leadership 5/12.

Activity pressure 0.48; No reversal markers Next-Week ExpectancyPositive 58.24%

Next-week expectancy is positive with a 58.24% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 5; Small Cap Core rank 3 SVQF83/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 65.0 of 375 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment45/100

Weighted news tone is neutral across 3 relevant articles.

Signify NV Revenue Breakdown – MUN:G14 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202615.30 EUR3.5%18.12 EUR19.54 EUR-0.85-25.236.7KOff
31 Jul 202614.78 EUR1.6%18.26 EUR19.58 EUR-0.70-26.3121.9KOff
24 Jul 202614.55 EUR-10.5%18.44 EUR19.63 EUR-0.72-26.3929.1KOff
17 Jul 202616.25 EUR-2.0%18.59 EUR19.69 EUR-0.60-17.293.1KOff
10 Jul 202616.59 EUR-0.7%18.67 EUR19.72 EUR-0.11-16.8311.0KOff
3 Jul 202616.71 EUR-1.3%18.75 EUR19.76 EUR0.20-18.931.4KOff
26 Jun 202616.93 EUR-18.8%18.82 EUR19.78 EUR0.64-14.584.0KOn
19 Jun 202620.86 EUR2.0%18.88 EUR19.81 EUR0.953.400On
12 Jun 202620.46 EUR-2.4%18.78 EUR19.80 EUR0.982.781.1KOn
5 Jun 202620.96 EUR0.8%18.72 EUR19.81 EUR1.024.68145On
29 May 202620.80 EUR1.3%18.64 EUR19.81 EUR1.042.512.1KOn
22 May 202620.54 EUR0.7%18.59 EUR19.80 EUR1.062.103.3KOff
15 May 202620.40 EUR3.2%18.58 EUR19.79 EUR0.815.433.5KOff
8 May 202619.77 EUR2.3%18.60 EUR19.79 EUR0.540.665.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context